India Highlights Progress on Universal Health Coverage, Hepatitis Elimination and Sickle Cell Care at UNGA81

1. At a Glance

• India used two side events at UNGA81 (New York) to present its health-systems model: Universal Health Coverage (UHC), viral hepatitis elimination and Sickle Cell Disease (SCD) care. [1]
• The common thread is a continuum of care. Primary care through Ayushman Arogya Mandirs is linked by referral to secondary and tertiary care, with financial protection and digital tracking. [1]
• Targets: eliminate Hepatitis B and C as public health threats by 2030, and Sickle Cell Anaemia as a public health problem by 2047. [1]
• Relevant for GS-II (health, governance, international groupings) and GS-III (technology). It also gives current data for Prelims.

2. Why in the News

• On the sidelines of UNGA81, Union Health Secretary Punya Salila Srivastava took part in the Seventh Annual Ministerial Meeting of the Group of Friends of UHC & Global Health. [1]
• She also spoke at the side event "Advancing Global Action to Eliminate Hepatitis". [1]
• India co-hosted the launch of OneSCD, a global partnership on sickle cell care. [1]
• PIB release dated 24 Sep 2026. [1]

3. Background & Evolution

• National Viral Hepatitis Control Programme: launched in 2018. About 225 million beneficiaries screened since. [1]
• National Sickle Cell Anaemia Elimination Mission: launched in 2023, with a goal of elimination as a public health problem by 2047. [1]
• The hepatitis programme sits within the National Health Mission (NHM) framework. [1]
• Further history (Ayushman Bharat's launch year, the origin of the UHC Group of Friends) is not in the retrieved source, so I have not stated it.

4. Core Static Facts

Item	Fact
Ayushman Arogya Mandirs	Over 1.8 lakh; services cover reproductive and child health, NCD screening, mental health, elderly and palliative care [1]
AB-PMJAY	Publicly funded health assurance scheme for financial protection of vulnerable sections [1]
Other financial-protection measures	Free Drugs and Diagnostics Service Initiative; Prime Minister's National Dialysis Programme [1]
Digital health	Over 900 million unique health IDs; ABHA-enabled records; interoperable registries of facilities and professionals [1]
Telemedicine	Over 497 million teleconsultations on e-Sanjeevani; teleradiology, AI-enabled X-rays, Mobile Medical Units [1]
Hepatitis	Screening at about 1.80 lakh facilities; 1,039 treatment centres; goal 2030 [1]
Hepatitis prevention	Mother-to-child transmission prevention under the RMNCAH framework [1]
SCD Mission	7.29 crore screened; over 20 lakh carriers; 2.5 lakh diagnosed; 4.93 crore Sickle Cell Cards [1]
OneSCD partners	Government of Nigeria, WHO, UNICEF, Africa CDC, World Coalition on Sickle Cell Disease, St. Jude Children's Research Hospital [1]

5. Multi-Dimensional Analysis

Social

• The SCD Mission targets screening, counselling and follow-up. Cards and digital tracking aim to keep diagnosed people connected to care. [1]
• AB-PMJAY, free drugs and diagnostics, and dialysis support reduce out-of-pocket burden for vulnerable groups. [1]

Scientific / Technological

• ABHA records, interoperable registries, e-Sanjeevani, AI-enabled X-rays and teleradiology are used to bridge geographic barriers. [1]

Geopolitical / Strategic

• India co-hosted OneSCD with Nigeria, Africa CDC and others, which fits its health-cooperation role with Africa. [1]
• India is positioning its UHC model at the UN through the Group of Friends of UHC. [1]

Administrative

• Hepatitis services are embedded in NHM and integrated across programmes (RMNCAH). [1]
• Quality standards in primary care remain a stated focus. [1]
• Referral linkages between primary, secondary and tertiary care are the integration mechanism. [1]

Ethical / Governance

• These are self-reported government figures, and outcome data (cure rates, incidence) are not given in the source. Screening numbers measure activity, not elimination progress. [1]

6. Recent Developments (last 12-18 months)

• 24 Sep 2026: PIB reports India's interventions at the UHC Group of Friends meeting, the hepatitis event and the OneSCD launch at UNGA81. [1]
• The source excerpt was truncated ("The Union Health Secretary also h…"), so any further points are not captured.

7. Prelims Hooks

• Group of Friends of UHC & Global Health: Seventh Annual Ministerial Meeting held at UNGA81. [1]
• India has over 1.8 lakh Ayushman Arogya Mandirs. [1]
• AB-PMJAY is a publicly funded health assurance scheme. [1]
• Over 900 million unique health identities exist; records are ABHA-enabled. [1]
• e-Sanjeevani has facilitated over 497 million teleconsultations. [1]
• Global hepatitis elimination goal: 2030. [1]
• National Viral Hepatitis Control Programme launched in 2018. [1]
• Viral hepatitis treatment centres: 1,039. [1]
• About 225 million people screened for viral hepatitis. [1]
• National Sickle Cell Anaemia Elimination Mission launched in 2023; target year 2047. [1]
• SCD Mission figures: 7.29 crore screened, 2.5 lakh diagnosed, 4.93 crore cards distributed. [1]
• OneSCD partners include Nigeria, WHO, UNICEF, Africa CDC and St. Jude. [1]

8. Why 225 Million Screened Does Not Mean Hepatitis Is Retreating

• Screening is the easy half. Treatment is the hard half.
• India has about 1.80 lakh places where you can get screened, but only 1,039 treatment centres [1].
• That is roughly 170 screening points for every one treatment centre.

• So a person who tests positive in a village must travel, often far, to start medicine. Many simply do not go. This step is called linkage to care (making sure a person who tests positive actually starts treatment).

• Hepatitis B is not a one-time cure. It is a lifelong course.

• Hepatitis C can usually be cured in about 12 weeks with tablets.
• Hepatitis B usually needs medicine for life, with regular blood tests.

• So one treatment centre does not treat a patient once; it must hold that patient for years. The 1,039 figure is a running load, not a one-time job [1].

• The global record shows exactly where this breaks.

• By end-2022, only 13% of people with hepatitis B worldwide had been diagnosed, and only 3% had received treatment [2].
• The WHO target is to treat 80% of people living with hepatitis B and C by 2030 [2].

• India is one of ten countries that together carry nearly two-thirds of the world's hepatitis B and C burden [2]. So the gap between 3% and 80% is largely India's gap to close.

• What to write in an answer: the correct measure of the 2030 goal is not people screened. It is how many diagnosed people are on treatment today, and still on it next year. The source gives no such number [1].

9. Sickle Cell: You Cannot Cure Your Way to 2047

• Sickle Cell Disease is inherited, so "elimination" means stopping new births, not curing patients.
• A child gets the disease only when both parents are carriers (a carrier has the gene but is usually healthy).
• India has found over 20 lakh carriers against 2.5 lakh actually diagnosed with the disease [1].

• So the 2047 target depends on genetic counselling (telling two carriers, before marriage or before a child, what the risk is). Building hospitals does not by itself move this target.

• The card gap is the follow-up gap.

• 7.29 crore people were screened, but only 4.93 crore Sickle Cell Cards were given out [1].
• That leaves roughly 2.36 crore screened people with no card in hand.

• The card is what carries a person's status to the next doctor and the next counsellor. Without it, the screening result stays in a file and does nothing for the person.

• Screening creates a label, and a label can hurt.

• A person marked as a carrier is healthy, but the tag can follow them into marriage talks and jobs.
• The source describes counselling and cards, but gives no confidentiality rule and no count of trained counsellors [1].
• This is the honest weak point of any mass genetic screening programme: the test is cheap and fast, the counselling is slow, skilled and expensive.

10. The One Number That Tests UHC: What Families Still Pay

• Universal Health Coverage is judged on money, not on buildings. The standard test is out-of-pocket expenditure, OOPE (the money a family pays from its own pocket at the time of treatment).
• India's own data shows real progress here, and it should be conceded plainly.
• Government data puts OOPE at about 39.4% of total health spending in 2021-22, down from about 62.6% earlier [3].
• Over the same stretch, the government's share of total health spending rose to about 48% [3].

• This is a genuine achievement and belongs in the answer, not only the criticism.

• But the note's own list shows what the figure cannot settle.

• AB-PMJAY, free drugs and dialysis are all named as financial protection tools [1], yet no OOPE figure appears anywhere in the UN presentation [1].

• A falling national average can still hide families pushed into poverty by one illness. That is measured separately, as catastrophic health expenditure (health spending large enough to wreck a household budget).

• What a senior answer does: quote the 39.4% as evidence the model is working, then say the missing test is whether hepatitis and sickle cell patients — who need medicine for years, not one hospital stay — are covered by schemes built mainly around hospital admission [1].

11. India's Real Bargaining Chip at the UN Is Cheap Medicine

• The note frames OneSCD as diplomacy. The harder point is what India actually brings to the table.
• WHO's own pricing data records India offering the lowest generic price for tenofovir, about US$1.20 for a 30-day supply (the standard hepatitis B medicine) [4].
• A full 12-week cure for hepatitis C — sofosbuvir with daclatasvir — starts at about US$40.40 in India [4].

• So India's pitch is not only its own programme. It is that Indian generic makers set the world's floor price for these medicines.

• This is why the Africa link matters.

• OneSCD partners include the Government of Nigeria, WHO, UNICEF and Africa CDC [1].
• Nigeria carries a very large sickle cell burden, and Africa CDC is the continent's own disease agency.

• India is offering two things it has and they need: mass screening experience at population scale [1] and cheap drug manufacturing [4].

• The honest limit: India is asking other countries to trust a model whose outcome numbers — cure rates, fall in new infections — are not yet published in this source [1]. Global partnerships are built on results data, and that is the next thing India will be asked for.

12. Anchors for Answers

• Data: Out-of-pocket expenditure fell to about 39.4% of total health spending (2021-22), with government share at about 48% [3]
• Data: Only 13% of people with hepatitis B worldwide were diagnosed and 3% treated by end-2022, against a 80% treatment target for 2030 [2]
• Data: India is among ten countries carrying nearly two-thirds of the global hepatitis B and C burden [2]
• Data: 1.80 lakh hepatitis screening facilities against only 1,039 treatment centres [1]
• Data: SCD Mission — 7.29 crore screened, 4.93 crore cards issued, 20 lakh carriers, 2.5 lakh diagnosed [1]
• Report: WHO Global Hepatitis Report, 2024 [4]; National Health Accounts Estimates for India [3]
• Comparison: India sets the world's lowest generic price — tenofovir at about US$1.20 for 30 days, a 12-week hepatitis C cure from about US$40.40 [4]
• Scheme: AB-PMJAY plus Free Drugs and Diagnostics and the PM National Dialysis Programme are the financial-protection leg of UHC; hepatitis work sits inside the National Health Mission [1]

13. Mains Relevance

• GS-II: Health; government policies and interventions; issues from the design and implementation of welfare schemes; important international institutions and groupings.
• GS-III: Science and technology applications in everyday life (digital health, AI).
• Possible questions:
• India's UHC strategy rests on a continuum of care from primary to tertiary level. Critically examine its financial-protection and digital components.
• Elimination targets for hepatitis (2030) and sickle cell (2047) require more than screening. Discuss the challenges.
• Assess India's role in shaping global health partnerships, with reference to OneSCD.

14. Related Topics to Study Next

• National Health Mission: the platform for hepatitis and other programmes.
• Ayushman Bharat Digital Mission / ABHA: the backbone of the digital health record system.
• WHO global viral hepatitis elimination strategy: the source of the 2030 goal.
• NCD screening and mental health services: part of the Mandirs' service package.
• Africa CDC and India-Africa health cooperation: the OneSCD context.
• Telemedicine guidelines and e-Sanjeevani: technology delivery.
• Financial protection metrics: out-of-pocket expenditure and catastrophic health spending.

15. Common Errors / Trap Areas

• Two different elimination years: hepatitis is 2030 (B and C) and sickle cell is 2047. [1]
• Screening versus treatment counts: 225 million screened for hepatitis is not the number treated. For SCD, 7.29 crore screened, 2.5 lakh diagnosed and 20 lakh carriers are separate figures. [1]
• Programme names: NVHCP (hepatitis, 2018) is not the SCD Mission (2023). [1]
• Scheme roles: AB-PMJAY is a health assurance scheme; the Free Drugs and Diagnostics Initiative and the National Dialysis Programme are separate. [1]
• Event confusion: UHC Group of Friends, the hepatitis side event and OneSCD are three separate engagements at UNGA81. [1]